Cyberonics (NASDAQ:CYBX), a company whose shares are moving quickly, is trading 1.8% higher to $56.30. The Dow is up 0.4% to 13,382 and the S&P is currently up 0.2% to 1,460.
Cyberonics (NASDAQ:CYBX) defies analysts with a current price ($56.30) 2.1% above its average consensus price target of $55.12. Cyberonics shares have support at the 50-day moving average (MA) of $50.31 and additional support at the 200-day MA of $45.45.
Cyberonics share prices have moved between a 52-week high of $56.73 and a 52-week low of $32.00 and are now trading 76% above that low price at $56.30 per share. Over the past week, the 200-day moving average (MA) has gone up 0.5% while the 50-day MA has advanced 0.8%.
Cyberonics, Inc. designs, develops, and markets medical devices. The Company's devices are used for the treatment of epilepsy and other debilitating neurological, psychiatric, and other disorders. Cyberonics' NCP System is approved for sale in the United States, Europe, Canada, and other markets.
